Bruce Kilpatrick, Partner, Addleshaw Goddard LLP

#239 No More Clouds on the Horizon? The UK CMA’s Investigation Into Microsoft’s Acquisition of Activision Blizzard

Microsoft’s proposed acquisition of Activision Blizzard was controversially blocked in its original form by the […]

Adrian van den Hoven, Director General, Medicines for Europe

#114 What Are the Generic and Biosimilar Industries Worried About? Current Competition Law Issues Impacting the Sector.

Generics and biosimilars are an important part of the pharmaceutical landscape in Europe. What are […]